Rusan Pharma Secures Dual PMDA GMP Approval

Rusan Pharma obtained Japan PMDA GMP approval for its API plant in Ankleshwar and ampoule FDF line in Dehradun.
The approval places Rusan among few global firms with both API and finished‑dosage‑formulation facilities certified by Japan’s stringent regulator.
Rusan Pharma, a leader in addiction and pain‑management drugs, also holds GMP accreditations from USFDA, Health Canada, EU, TGA and others.
Managing Director Dr. Kunal Saxena hailed the milestone as strengthening Rusan’s position as a trusted global manufacturing partner.